Long-term outcomes of conservative versus invasive approach of coronary aneurysm - 31/12/22
, F. Campelo-Parada 1, V. Nader 1, T. Lhermusier 2, F. Bouisset 3, S. Blanco 1, J. Roncalli 1, D. Carrié 4Résumé |
Introduction |
Up to date, the management of coronary artery aneurysm (CAA) is not well defined and depends on local heart team decision. Data reported in literature are scarce and controversial.
Objective |
We aim to compare the long-term outcomes of different therapeutic strategies of CAA (medical vs. PCI vs. CABG).
Method |
A retrospective cohort study was conducted on 100 consecutive patients who underwent coronary angiography at Toulouse University Hospital, Toulouse France and fulfilled the diagnostic criteria of CAA. Coronary angiograms were reviewed and all necessary data were collected. CAA was defined by a coronary dilation exceeding at least 50% of reference coronary diameter.
Results |
We identified 100 patients with CAA with a mean age of 67.9±12years. The left anterior descending coronary artery was most commonly affected (36%). CAA is associated with significant coronary artery disease in 78% of cases. The incidence of major adverse cardiovascular and cerebrovascular events (MACE) was 13% during median follow-up period of 46.2±24months. A 53% of patients underwent PCI or CABG. Outcomes were similar between study groups [CABG (9.1%), PCI (14.3%) and medical (12.8%)] (Fig. 1). No benefits have been attributed to anticoagulant regimen (Fig. 2).
Conclusion |
There is no significant difference in MACE free-survival between all-groups (medical vs. PCI vs. CABG).
Le texte complet de cet article est disponible en PDF.Plan
Vol 15 - N° 1
P. 10-11 - janvier 2023 Retour au numéro
Article précédent
- Long-term follow-up of diabetic patients with non-ST-elevation acute coronary syndrome in the era of invasive management
- F. Boukerche, L. Hammou, N. Laredj
- Impact of the COVID-19 pandemic on overall percutaneous coronary interventions from the France-PCI registry: Comparative analysis of the years 2019 and 2020
- H. Mesrar, R. Hakim, S. Chassaing, O. Fichaux, P. Marcollet, M.-P. Decomis, F. Beygui, D. Angoulvant, P. Motreff, G. Rangé
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?